GOLDMAN SACHS GROUP INC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 54 filers reported holding PROQR THRAPEUTICS N V in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2022$117,000
-5.6%
157,910
-1.2%
0.00%
Q2 2022$124,000
-82.3%
159,796
-79.4%
0.00%
Q1 2022$702,000
-97.8%
775,935
-80.2%
0.00%
-100.0%
Q4 2021$31,346,000
+9.1%
3,913,394
+14.0%
0.01%0.0%
Q3 2021$28,726,000
+27.9%
3,432,069
+3.0%
0.01%
+20.0%
Q2 2021$22,462,000
+2.6%
3,332,570
+0.6%
0.01%
-16.7%
Q1 2021$21,896,000
+58.4%
3,312,507
+0.7%
0.01%
+50.0%
Q4 2020$13,822,000
-13.0%
3,291,035
-0.8%
0.00%
-20.0%
Q3 2020$15,888,000
-21.3%
3,316,837
-0.0%
0.01%
-16.7%
Q2 2020$20,176,000
+10.6%
3,318,374
-0.1%
0.01%0.0%
Q1 2020$18,236,000
-45.1%
3,321,703
-0.9%
0.01%
-25.0%
Q4 2019$33,200,000
+73.5%
3,350,192
+0.8%
0.01%
+33.3%
Q3 2019$19,135,000
-37.1%
3,322,107
-0.6%
0.01%
-33.3%
Q2 2019$30,424,000
-37.9%
3,343,322
-5.3%
0.01%
-40.0%
Q1 2019$48,969,000
-8.9%
3,530,568
+3.7%
0.02%
-11.8%
Q4 2018$53,748,000
+33077.8%
3,406,102
+30489.2%
0.02%
Q3 2015$162,000
-13.8%
11,135
-1.2%
0.00%
Q2 2015$188,000
-54.9%
11,273
-40.8%
0.00%
Q1 2015$417,000
+70.9%
19,049
+69.0%
0.00%
Q4 2014$244,00011,2700.00%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q2 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders